The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen modulation.
Naphthalene compounds as selective estrogen receptor modulators
申请人:Glaxo Smith Kline LLC
公开号:US07649093B2
公开(公告)日:2010-01-19
The present invention relates to cycloalkylidene compounds with a variety of therapeutic uses, more particularly novel naphthalene compounds that are particularly useful for selective estrogen receptor modulation.